Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy.
Pulicken
Mathew
M
Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Koteish
Ayman
A
DeBusk
Karen
K
Calabresi
Peter A
PA
D000328:Adult; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005260:Female; D019693:Hepatitis, Autoimmune / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000008:administration & dosage* / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*
D007155:Immunologic Factors; D016899:Interferon-beta; D000068556:Interferon beta-1a